NF1 Tumor Suppressor Gene Function

Slides:



Advertisements
Similar presentations
Presented by: Jacqueline Holt March 4th 2003
Advertisements

Neurofibromatosis 1 von Recklinghausen Syndrome Kristin Neitzke.
Figure 1. Figure 2 Somatic Mutation Summary A A A98-07-F009a tumor mutant reads > 10 normal mutant read = 0 tumor mutant fraction.
Neurofibromatosis type 1. Biallelic NF1 inactivation leads to multiple symptoms.
Specific Disruption of a Schwann Cell Dystrophin-Related Protein Complex in a Demyelinating Neuropathy Diane L Sherman, Cinzia Fabrizi, C.Stewart Gillespie,
NF1 (Neurofibromatosis Type 1) Greg Hogan Ribbon Representation of NF1-333 Scheffzek, et al. (The EMBO Journal Vol. 17,pp , 1998) Structural.
Cultured Schwann Cells Constitutively Express the Myelin Protein P0 Lili Cheng, Anne W Mudge Neuron Volume 16, Issue 2, Pages (February 1996) DOI:
Have a positive role in cell division Have a negative role in cell division Have a role in the maintenance of DNA integrity Genes altered in cancer typically:
THE GENETIC BASIS OF CANCER
Cell Communication.
Neurofibromatosis 1 Valerie Khodush March 27, 2007
Neurofibromatosis Type I (NF1)
Oncogene at last—c-Jun promotes liver cancer in mice
Volume 152, Issue 5, Pages (April 2017)
“Atypical” Regulation of Hedgehog-Dependent Cancers
Genetics of Cancer.
PI3K Regulatory Subunits Lose Control in Cancer
HSF1 in Translation Cancer Cell
Volume 150, Issue 3, Pages (September 2018)
G. Aaron Hobbs, Alfred Wittinghofer, Channing J. Der  Cancer Cell 
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
RASAL2: Wrestling in the Combat of Ras Activation
A genome-based strategy uncovers frequent BRAF mutations in melanoma
Toward a Survey of Somatic Mutation of the NF1 Gene in Benign Neurofibromas of Patients with Neurofibromatosis Type 1  Ingrid Eisenbarth, Kim Beyer, Winfrid.
Plant hormones: Dissecting the gibberellin response pathway
Metabolic Networks of Longevity
Volume 6, Issue 3, Pages (September 2004)
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Mechanisms of Asymmetric Stem Cell Division
RASopathy Gene Mutations in Melanoma
Volume 3, Issue 4, Pages (April 2003)
Roles for KRAS in Pancreatic Tumor Development and Progression
Cooperation between Noncanonical Ras Network Mutations
Searching for the Chokehold of NRAS Mutant Melanoma
Volume 10, Issue 6, Pages (December 2006)
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations  Iiro Eerola, Laurence M. Boon, John.
Shyam S. Jayaraman, David J. Rayhan, Salar Hazany, Michael S. Kolodney 
Volume 15, Issue 3, Pages (March 2014)
Signaling Interplay in Ras Superfamily Function
RAS Proteins and Their Regulators in Human Disease
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease
GEFs and GAPs: Critical Elements in the Control of Small G Proteins
Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK
NO Signals from the Cancer Stem Cell Niche
NF GEMMs Already! The Power and Promise of Mouse Tumor Models
Function of Rab3 GDP–GTP Exchange
Haploinsufficiency at the Nkx3.1 locus
Volume 92, Issue 3, Pages (February 1998)
aMAGEing New Players Enter the RING to Promote Ubiquitylation
Just-So Stories and Origin Myths: Phosphorylation and Structural Disorder in Circadian Clock Proteins  Jay C. Dunlap, Jennifer J. Loros  Molecular Cell 
Hirokatsu Yanagihori, Noritaka Oyama, Koichiro Nakamura, Fumio Kaneko 
Volume 23, Issue 4, Pages (August 1999)
Drug Discovery and Chemical Biology of Cancer Epigenetics
The Ran GTPase: Theme and Variations
SUR-8, a Conserved Ras-Binding Protein with Leucine-Rich Repeats, Positively Regulates Ras-Mediated Signaling in C. elegans  Derek S Sieburth, Qun Sun,
Mutations and aneuploidy
Selfish Stem Cells Compete with Each Other
To Infinium, and Beyond! Cancer Cell
Guilty as charged Cancer Cell
All Roads Lead to the Ribosome
Regulation of Angiogenesis and Tumorigenesis by Signal Transduction Cascades: Lessons from Benign and Malignant Endothelial Tumors  Robert Klafter, Jack.
Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma  Marc R. Mansour, A. Thomas Look  Cancer Cell 
Apoptosis: Activate NF-κB or die?
Helge Großhans, Ingo Büssing  Cancer Cell 
Mutational Analysis of Ionizing Radiation Induced Neoplasms
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Volume 3, Issue 4, Pages (April 2003)
Presentation transcript:

NF1 Tumor Suppressor Gene Function Karen Cichowski, Tyler Jacks  Cell  Volume 104, Issue 4, Pages 593-604 (February 2001) DOI: 10.1016/S0092-8674(01)00245-8

Figure 1 Sequence Similarity among Ras-GAP Proteins Similarity of neurofibromin with the mammalian p120 RasGAP and yeast RasGAP proteins IRA1 and IRA2. Note the similarity with IRA proteins extending beyond the catalytic GAP-related domain (GRD). Src-homology 2 (SH2), Src-homology 3 (SH3), and pleckstrin homology (PH) domains are only present in p120 RasGAP Cell 2001 104, 593-604DOI: (10.1016/S0092-8674(01)00245-8)

Figure 2 Neurofibromin Functions as a Ras-GAP (A) RasGAP proteins such as neurofibromin inactivate Ras by catalyzing the hydrolysis of Ras-GTP to Ras-GDP. Exchange factors activate Ras by potentiating the exchange of GDP for GTP. (B) Simplified version of the Ras pathway. Genes encoding highlighted proteins have been found to be mutated or amplified in human cancer (blue) Cell 2001 104, 593-604DOI: (10.1016/S0092-8674(01)00245-8)

Figure 3 Normal Peripheral Nerve and Model of Neurofibroma Development (A) Peripheral nerves are comprised of multiple cell types; neurons (blue), Schwann cells (red), perineurial cells (gray) and fibroblasts (yellow). Occasional mast cells are also observed (green). (B) Neurofibromas exhibit an increased number of all cell types. In addition, Schwann cells are often dissociated from neurons and the perineurium is disrupted. (C) Neurofibroma development may be initiated by mutation or loss of the inherited wild-type NF1 allele in Schwann cells (pink cells are NF1−/− ). This may trigger tumor development by initiating a cascade of changes in other cell types as a result of their interdependency and/or haploinsufficiency. Wounding and hormonal exposure may also promote development Cell 2001 104, 593-604DOI: (10.1016/S0092-8674(01)00245-8)